IP Library › Assignment 072925/0519
Patent Assignment
Reel/Frame 072925/0519

Assignment of Assignor's Interest

Recorded: 2025-09-24 Pages: 8
Assignor
PETTINE, KENNETH ALLEN
Executed: 2025-09-08
Assignee
DIRECT BIOLOGICS, LLC
5301 SOUTHWEST PARKWAY, BLDG. 1, SUITE 415, AUSTIN, TEXAS, 78735
Covered Properties (69)
A Growth Factor and Extracellular Vesicle Frozen or Powdered Additive Comprising a Mesenchymal Stem Cell (Msc) Preparation and Methods of Use
Methods and Compositions for Treating Skin and Hair Disorders
Isolation and Use of Autogenous Platelet Derived Exosomes
Methods and Compositions for Developing Target Specific Exosome and Growth Factor Products
Method for Treating Osteoarthritis with a Combination of Mesenchymal Stem Cell Exosomes, Synovial Mesencymal Stem Cells, and Scaffolds
Acellular Intravenous Infusion Including Mesenchymal Stem Cell Growth Factors and Exosomes
Method for the Treatment of Periodontal Disease Using Characterized Mesenchymal Stem Cell Growth Factors and Exosomes
Preparations Comprising Mesenchymal Stem Cells and Cannabinoids and Methods of Their Use
Methods and Compositions for Treating Inflammatory Conditions Associated with Infectious Disease
Treatment of Fistula with Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles
Treatment of Complex Regional Pain Syndrome with Extracellular Vesicle Composition
Treatment of Amyotrophic Lateral Sclerosis with Extracellular Vesicle Composition
Treatment of Long Covid with Extracellular Vesicle Composition
Treatment of Lumbar Facet Joint Syndrome with Extracellular Vesicle Composition
Treatment of Radiated Skin with Extracellular Vesicle Composition
Treatment for Solid Abdominal Organ Transplantation with Extracellular Vesicle Composition
Treatment of Infertility with Extracellular Vesicle Composition
Treatment of Ehlers-Danlos Syndrome with Extracellular Vesicle Composition
Treatment of Traumatic Brain Injury with Extracellular Vesicle Composition
Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles to Improve Perioral Area and Face Fat Graft Retention
A Mesenchymal Stem Cell (Msc) Growgh Factor and Extracellular Vesicle Preparation in Frozen of Powdered Form and Methods of Use
Application: 17/059,874 →
Publication: US 2021/0196759
Methods and Compositions for Treating Skin and Hair Disorders
Application: 17/418,342 →
Publication: US 2022/0079990
Isolation and Use of Autogenous Platelet Derived Exosomes
Application: 17/420,500 →
Publication: US 2022/0079987
Methods and Compositions for Developing Target Specific Exosome and Growth Factor Products
Application: 17/427,192 →
Publication: US 2022/0136053
Method for Treating Osteoarthritis with Mesenchymal Stem Cell Exosomes
Application: 17/429,553 →
Publication: US 2022/0125848
Acellular Intravenous Infusion Including Mesenchymal Stem Cell Growth Factors and Exosomes
Application: 17/432,138 →
Publication: US 2022/0152151
Method for the Treatment of Periodontal Disease Using Characterized Mesenchymal Stem Cell Growth Factors and Exosomes
Application: 17/606,514 →
Publication: US 2022/0202871
Preparations Comprising Mesenchymal Stem Cells and Cannabinoids and Methods of Their Use
Application: 17/628,011 →
Publication: US 2022/0257661
Methods and Compositions for Treating Inflammatory Conditions Associated with Infectious Disease
Application: 17/920,997 →
Publication: US 2023/0159932
Preparations Comprising Mesenchymal Stem Cells and Cannabinoids and Methods of Their Use
Application: 18/988,110 →
Publication: US 2025/0186501
Methods and Compositions for Treating Inflammatory Conditions Associated with Infectious Disease
Application: 19/098,197 →
Publication: US 2025/0277217
Treatment of Fistula with Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles
Application: 19/205,490 →
Publication: US 2025/0332200
Method for Treating Osteoarthritis with Mesenchymal Stem Cell Exosomes
Application: 19/256,922 →
Publication: US 2025/0381228
Stem Cell Collagen Powder
Application: 62/677,744 →
Dermatological and Cosmetic Treatments Using Mesenchymal Stem Cells or Mesenchymal Stem Cell Growth Factor Powder
Application: 62/681,172 →
Wound Healing, Orthopedic, and Spine Treatments Using Mesenchymal Stem Cells or Mesenchymal Stem Cell Growth
Application: 62/688,012 →
Method for the Treatment of Pain, Inflammation, Neurologic Disorders and Autoimmune Diseases with Mesenchymal Stem Cell Exosomes and Secretomes to Replace Current Therapies, Opioids and Analgesics
Application: 62/698,673 →
Skin Color and Race Specific Dermatological and Cosmetic Treatments and Methods of Making Such Treatments
Application: 62/785,072 →
Composition and Method for Preventing and Treating Grey Hair
Application: 62/785,126 →
Composition and Method for Preventing and Treating Baldness
Application: 62/785,155 →
Composition and Method for Preventing and Treating Erectile Dysfunction
Application: 62/787,672 →
Isolation and Use of Autogenous Platelet Derived Exosomes
Application: 62/788,545 →
Method for Developing Target Specific Exosome and Growth Factor Products by Rna, Protein, and Single Nucleotide Polymorphism Characterization and Manipulation
Application: 62/798,908 →
Method for Treating Osteoarthritis with a Combination of Mesenchymal Stem Cell Exosomes, Synovial Mesencymal Stem Cells, and Scaffolds
Application: 62/802,310 →
Acellular Intravenous Infusion Including Mesenchymal Stem Cell Growth Factors and Exosomes
Application: 62/807,610 →
Method for the Treatment of Periodontal Disease Using Characterized Mesenchymal Stem Cell Growth Factors and Exosomes
Application: 62/839,975 →
Acellular Intravenous Infusion Including Mesenchymal Stem Cell Growth Factors, Exosomes and Cannabidiol
Application: 62/875,889 →
Method for Treating Inflammatory Arthritis with a Transdermal Delivery of Mesenchymal Stem Cell Exosomes
Application: 62/908,853 →
Method and Composition for the Delivery of Mesenchymal Stem Cell Derived Exosomes and Cannabinoids via Inhalation Delivery Systems
Application: 62/951,905 →
Method for Treating Viruses Using Mesenchymal Stem Cell Derived Exosomes
Application: 63/013,865 →
Antiviral Biomolecule Composition
Application: 63/198,706 →
Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicle Infusion for Amyotrophic Lateral Sclerosis
Application: 63/507,204 →
Safety and Efficacy of Intravenous Exoflo in the Treatment of Complex Regional Pain Syndrome
Application: 63/507,207 →
Treatment of Infertility with Extracellular Vesicle Composition
Application: 63/563,042 →
Treatment of Ehlers-Danlos Syndrome with Extracellular Vesicle Composition
Application: 63/568,282 →
Treatment of Amyotrophic Lateral Sclerosis with Extracellular Vesicle Composition
Application: 63/570,632 →
Treatment of Lumbar Facet Joint Syndrome with Extracellular Vesicle Composition
Application: 63/596,900 →
Treatment for Solid Abdominal Organ Transplantation with Extracellular Vesicle Composition
Application: 63/596,952 →
Treatment of Radiated Breast Skin with Extracellular Vesicle Composition
Application: 63/596,953 →
Treatment of Long COVID with Extracellular Vesicle Composition
Application: 63/596,955 →
Treatment of Long COVID with Extracellular Vesicle Composition
Application: 63/631,680 →
Treatment of Traumatic Brain Injury with Extracellular Vesicle Composition
Application: 63/638,077 →
Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles to Improve Perioral Area and Face Fat Graft Retention
Application: 63/638,207 →
Treatment of Fistula with Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles
Application: 63/638,807 →
Treatment of Ehlers-Danlos Syndrome with Extracellular Vesicle Composition
Application: 63/705,416 →
Treatment of Lumbar Facet Joint Syndrome with Extracellular Vesicle Composition
Application: 63/712,038 →
Treatment of Radiated Breast Skin with Extracellular Vesicle Composition
Application: 63/712,045 →
Treatment of Long Covid with Extracellular Vesicle Compositions
Application: 63/712,052 →
Treatment for Solid Abdominal Organ Transplantation with Extracellular Vesicle Composition
Application: 63/712,072 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Nunc Pro Tunc Assignment Mar 11, 2020
From: PETTINE, KENNETH ALLEN
To: DIRECT BIOLOGICS LLC
Reel/Frame 052145/0648 →
Nunc Pro Tunc Assignment Apr 8, 2021
From: MOSELEY, TIMOTHY ALEXANDER
To: DIRECT BIOLOGICS LLC
Reel/Frame 055870/0584 →
Nunc Pro Tunc Assignment Sep 1, 2021
From: PETTINE, KENNETH ALLEN
To: DIRECT BIOLOGICS LLC
Reel/Frame 057393/0691 →
Assignment of Assignor's Interest Dec 9, 2022
From: HICOK, KEVIN; MOSELEY, TIMOTHY; PETTINE, KENNETH
To: DIRECT BIOLOGICS LLC
Reel/Frame 062039/0568 →
Assignment of Assignor's Interest Feb 3, 2023
From: PETTINE, KENNETH ALLEN; MOSELEY, TIMOTHY ALEXANDER
To: DIRECT BIOLOGICS LLC
Reel/Frame 062583/0077 →
Assignment of Assignor's Interest Jun 14, 2023
From: PETTINE, KENNETH ALLEN
To: DIRECT BIOLOGICS LLC
Reel/Frame 063949/0049 →
Assignment of Assignor's Interest Jun 21, 2023
From: PETTINE, KENNETH ALLEN; MOSELEY, TIMOTHY ALEXANDER
To: DIRECT BIOLOGICS LLC
Reel/Frame 064013/0071 →
Assignment of Assignor's Interest Jul 18, 2023
From: PETTINE, KENNETH ALLEN; MOSELEY, TIMOTHY ALEXANDER
To: DIRECT BIOLOGICS LLC
Reel/Frame 064302/0867 →
Assignment of Assignor's Interest Aug 8, 2023
From: PETTINE, KENNETH ALLEN
To: DIRECT BIOLOGICS LLC
Reel/Frame 064517/0902 →
Assignment of Assignor's Interest Aug 28, 2023
From: PETTINE, KENNETH ALLEN
To: DIRECT BIOLOGICS LLC
Reel/Frame 064717/0470 →
Assignment of Assignor's Interest Aug 28, 2023
From: MOSELEY, TIMOTHY ALEXANDER; PETTINE, KENNETH ALLEN
To: DIRECT BIOLOGICS LLC
Reel/Frame 064716/0786 →
Assignment of Assignor's Interest Oct 17, 2024
From: PETTINE, KENNETH ALLEN; PAICIUS, RICHARD
To: DIRECT BIOLOGICS, LLC
Reel/Frame 068929/0685 →
Assignment of Assignor's Interest Oct 17, 2024
From: MOSELEY, TIMOTHY ALEXANDER
To: DIRECT BIOLOGICS, LLC
Reel/Frame 068929/0637 →
Assignment of Assignor's Interest Mar 6, 2025
From: MOSELEY, TIMOTHY ALEXANDER
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070430/0394 →
Assignment of Assignor's Interest Mar 6, 2025
From: PETTINE, KENNETH ALLEN; SCHMIDT, EMIL J., IV; WILSON, JAMES E.
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070430/0552 →
Assignment of Assignor's Interest Mar 6, 2025
From: MOSELEY, TIMOTHY ALEXANDER
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070430/0591 →
Assignment of Assignor's Interest Mar 6, 2025
From: PETTINE, KENNETH ALLEN; SCHMIDT, EMIL J., IV; BLIGH, RICHARD
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070430/0628 →
Assignment of Assignor's Interest Mar 6, 2025
From: MOSELEY, TIMOTHY ALEXANDER
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070430/0684 →
Assignment of Assignor's Interest Mar 6, 2025
From: PETTINE, KENNETH ALLEN
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070430/0694 →
Assignment of Assignor's Interest Mar 6, 2025
From: PETTINE, KENNETH ALLEN; SCHMIDT, EMIL J., IV; JANSEN, DAVID
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070430/0776 →
Assignment of Assignor's Interest Mar 6, 2025
From: MOSELEY, TIMOTHY ALEXANDER
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070430/0805 →
Assignment of Assignor's Interest Mar 6, 2025
From: PETTINE, KENNETH ALLEN; SCHMIDT, EMIL J., IV
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070436/0841 →
Assignment of Assignor's Interest Mar 6, 2025
From: MOSELEY, TIMOTHY ALEXANDER
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070437/0489 →
Assignment of Assignor's Interest Apr 21, 2025
From: HICOK, KEVIN; MOSELEY, TIMOTHY; PETTINE, KENNETH
To: DIRECT BIOLOGICS, LLC
Reel/Frame 070898/0866 →
Assignment of Assignor's Interest May 13, 2025
From: PETTINE, KENNETH ALLEN
To: DIRECT BIOLOGICS, LLC
Reel/Frame 071101/0740 →